News and Trends 3 Oct 2022
Canada injecting $11.1M into mRNA vaccine technology at University of British Columbia
The Canadian government is providing more than C$11.1 million (US$8.1 million) for two new mRNA vaccine projects at the University…
mRNA technology
- Latest Posts
News and Trends 19 Sep 2022
Global consortium looks to develop breakthrough RNA-based anti-cancer immunotherapy
The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a…
News and Trends 14 Sep 2022
Capstan Therapeutics launches with $165M to deliver on in vivo cell engineering
Capstan Therapeutics, Inc. has launched today with $165 million in financing to combine cell therapy and genetic medicines to help…
News and Trends 7 Sep 2022
Benchling launches solution to boost mRNA and RNA therapeutics development
Benchling has launched what it says is the industry’s first full set of capabilities for designing, modeling, and studying natural…
ADVERTISEMENT
News and Trends 6 Sep 2022
Lonza and Touchlight collaboration will expands customer’s access to DNA
Manufacturing partner, Lonza, has today (September 6) announced a collaboration with Touchlight, a biotech company that works with enzymatic DNA…
News and Trends 30 Aug 2022
Potential new cancer treatment target discovered by researchers in Sweden
A previously unknown mechanism that can control tumor growth in cultured cells and mice has been identified by researchers at…
News and Trends 29 Aug 2022
Strategic collaboration announced in China to accelerate the development of bacterial drugs
A strategic cooperation between Porton Advanced Solutions and Suzhou Royaltech Med Co., Ltd was announced today (August 29). The companies…
News and Trends 24 Aug 2022
Millions in funding and new board members for Belgian mRNA company
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing. Belgium-based eTheRNA will use the…
News and Trends 20 Jul 2022
IVI and Moderna sign MOU for vaccine R&D
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable…
News and Trends 8 Jul 2022
Cancer therapeutics company’s double win with $25M funding, and appointment of new board member
An mRNA-technology company developing cancer therapeutics designed to improve patients' survival rate and quality of life — this week announced…
ADVERTISEMENT
News and Trends 6 Jul 2022
Exyte Builds mRNA Competence Center for WACKER in Germany
A messenger ribonucleic acid (mRNA) competence center is being built at the Halle Biotech site of German company Wacker Chemie…
In Depth 4 Jul 2022
The COVID-19 pandemic has driven RNA therapeutics into the mainstream
As messenger RNA vaccines save lives around the world, and RNA interference drugs are greenlit for rare diseases, the field…
News and Trends 24 Jun 2022
Covid and malaria vaccines on track for mass production in Rwanda
Construction of the first African messenger RNA (mRNA) manufacturing facility has started in Africa. This means Biopharmaceutical New Technologies (BioNTech)…
News and Trends 21 Jun 2022
New agreement could lead to first African-owned COVID-19 vaccine
A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the…
News and Trends 15 Jun 2022
Eurocine Vaccines expands portfolio to develop HSV-2 vaccine
Swedish company Vaccines AB (Eurocine Vaccines) has entered into a research and collaboration agreement with Redbiotec AG. The agreement gives…
News and Trends 9 Jun 2022
Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods
Belgian biopharma firm Ziphius Vaccines is set to collaborate with the University of Antwerp to research and develop a lipid…
ADVERTISEMENT
News and Trends 31 May 2022
Therapeutic RNA company receives additional funding
UK biotech company Transine Therapeutics, which is developing a novel class of therapeutic RNAs, has successfully raised £4.6M ($5.8M) in…
News and Trends 1 Feb 2022
Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA
Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M Series B round, the German…
News and Trends 17 Aug 2021
Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are interested in messenger RNA technologies…
News and Trends 15 Jun 2021
Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met with hostility from many big…